SCHEMBL14340316

SCHEMBL14340316

C[Si](C)(C)c1ccc(-c2c3ccccc3c(-c3ccc(-c4ccc5cc(-c6c7ccccc7c(-c7ccccc7)c7ccccc67)ccc5c4)cc3)c3ccccc23)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ESR1 P03372 9/20 0.43
▸ ESR2 Q92731 7/20 0.43
▸ CYP11B1 P15538 2/20 0.41
▸ CYP11B2 P19099 2/20 0.41
▸ BACE1 P56817 1/20 0.39
▸ GPR84 Q9NQS5 1/20 0.38
▸ PGR P06401 1/20 0.38
▸ CYP1A2 P05177 2/20 0.38
▸ TRIM58 Q8NG06 1/20 0.38
▸ CYP3A4 P08684 1/20 0.38
▸ CYP2D6 P10635 1/20 0.38
▸ CYP2C9 P11712 1/20 0.38
▸ HSD17B1 P14061 1/20 0.38
▸ CYP2B6 P20813 1/20 0.38
▸ CYP2C19 P33261 1/20 0.38
▸ HSD17B2 P37059 1/20 0.38
▸ GAA P10253 1/20 0.37
▸ L3MBTL1 Q9Y468 1/20 0.37
▸ KDM4E B2RXH2 1/20 0.37
▸ MEN1 O00255 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL125736 0.94 ESR1 (0.42) ESR1ESR2CYP11B1CYP11B2BACE1
SCHEMBL16805209 0.93 ESR1 (0.41) ESR1ESR2CYP11B1CYP11B2GPR84
SCHEMBL4084190 0.92 IKBKB (0.42) ESR1ESR2CYP11B1CYP11B2GPR84
SCHEMBL20110000 0.91 HSD17B1 (0.44) ESR1ESR2CYP11B1CYP11B2GPR84
SCHEMBL13007010 0.89 ESR1 (0.41) ESR1ESR2CYP11B1CYP11B2GPR84
SCHEMBL124687 0.89 ESR1 (0.43) ESR1ESR2CYP11B1CYP11B2GPR84
SCHEMBL125705 0.89 ESR1 (0.43) ESR1ESR2CYP11B1CYP11B2GPR84
SCHEMBL126430 0.88 ESR1 (0.42) ESR1ESR2CYP11B1CYP11B2GPR84
SCHEMBL22180633 0.88 ACHE (0.44) ESR1ESR2L3MBTL1KDM4EALDH1A1
SCHEMBL23027127 0.87 ESR1 (0.39) ESR1ESR2CYP11B1CYP11B2GPR84

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070285009-A1 BISANTHRACENE DERIVATIVE AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME IDEMITSU KOSAN CO., LTD. (JP) 2007-12-13 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070285009-A1 BISANTHRACENE DERIVATIVE AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME EED, PARG, L1CAM ESR1 296/4885ESR2 444/4885CYP11B1 1940/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback